Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
20.7M
-
Shares change
-
+743K
-
Total reported value, excl. options
-
$556M
-
Value change
-
+$24M
-
Put/Call ratio
-
0.58
-
Number of buys
-
49
-
Number of sells
-
-56
-
Price
-
$26.94
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2022
136 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q1 2022.
TransMedics Group, Inc. - Common Stock (TMDX) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.7M shares
of 33.9M outstanding shares and own 60.88% of the company stock.
Largest 10 shareholders include FMR LLC (4.2M shares), MACQUARIE GROUP LTD (2.08M shares), Sandhill Capital Partners LLC (1.91M shares), BlackRock Inc. (1.89M shares), CREDIT SUISSE AG/ (1.52M shares), VANGUARD GROUP INC (1.33M shares), STATE STREET CORP (670K shares), Bank of New York Mellon Corp (590K shares), Bellevue Group AG (581K shares), and KORNITZER CAPITAL MANAGEMENT INC /KS (512K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.